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Background: The northern territory Nunavut has Canada’s largest jurisdictional land mass with 33,322 inhabitants,
of which 85% self-identify as Inuit. Nunavut has rates of infant mortality, postneonatal mortality and hospitalisation
of infants for respiratory infections that greatly exceed those for the rest of Canada. The infant mortality rate in
Nunavut is 3 times the national average, and twice that of the neighbouring territory, the Northwest Territories.
Nunavut has the largest Inuit population in Canada, a population which has been identified as having high rates of
Sudden Infant Death Syndrome (SIDS) and infant deaths due to infections.
Methods: To determine the causes and potential risk factors of infant mortality in Nunavut, we reviewed all infant
deaths (<1yr) documented by the Nunavut Chief Coroner’s Office and the Nunavut Bureau of Statistics (n=117;
1999–2011). Rates were compared to published data for Canada.
Results: Sudden death in infancy (SIDS/SUDI; 48%) and infection (21%) were the leading causes of infant death,
with rates significantly higher than for Canada (2003–2007). Of SIDS/SUDI cases with information on sleep position
(n=42) and bed-sharing (n=47), 29 (69%) were sleeping non-supine and 33 (70%) were bed-sharing. Of those
bed-sharing, 23 (70%) had two or more additional risk factors present, usually non-supine sleep position. CPT1A
P479L homozygosity, which has been previously associated with infant mortality in Alaska Native and British
Columbia First Nations populations, was associated with unexpected infant death (SIDS/SUDI, infection) throughout
Nunavut (OR:3.43, 95% CI:1.30-11.47).
Conclusion: Unexpected infant deaths comprise the majority of infant deaths in Nunavut. Although the CPT1A
P479L variant was associated with unexpected infant death in Nunavut as a whole, the association was less
apparent when population stratification was considered. Strategies to promote safe sleep practices and further
understand other potential risk factors for infant mortality (P479L variant, respiratory illness) are underway with local
partners.
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infancy, Carnitine palmitoyltransferase 1 deficiency, CPT1A P479L variantBackground
Nunavut, a northern Canadian territory covering the
most northern and eastern area of Canada, is Canada’s
largest jurisdictional land mass with 33,322 inhabitants,
of which 85% self-identify as Inuit [1,2]. Nunavut leads
the country in adverse early child health outcomes* Correspondence: larbour@uvic.ca
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reproduction in any medium, provided the orsuch as infant mortality [3], congenital anomalies [4],
prematurity, and low birth weight [5,6]. The infant
mortality rate in the territory (14.6/1,000 live births) is
three times higher than the national average (5.2/1,000
live births) and twice that of the Northwest Territories
(1999–2009) [3].
An estimated 850 infants are born in Nunavut each
year, with 90-95% of those being born to Inuit women
[2,5]. There are 25 communities in the three regions
of Nunavut: Qikiqtani, Kivalliq and Kitikmeot. Most
Nunavut communities are isolated geographically andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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delivered out of territory in Ontario (Qikiqtani), Manitoba
(Kivalliq), and the Northwest Territories (Kitikmeot)
[7,8]. Approximately 45% of births to Nunavut residents
occur out of territory [9].
In 2010, Luo et al. [10] reported that Sudden Infant
Death Syndrome (SIDS) and infection were the leading
causes of infant death in Inuit-inhabited regions of
Canada between 1990 and 2000. SIDS is a diagnosis of
exclusion where the cause of death remains unexplained
after a thorough investigation, including a complete aut-
opsy, examination of the death scene, and review of clin-
ical history [11]. Sudden Unexpected Death in Infancy
(SUDI) is a broader category that includes unexpected
infants deaths with other risk factors present, such as an
illness or risk factors for asphyxia [12,13].
The causes of SIDS and SUDI are multi-factorial, due
to a combination of environmental, developmental and
genetic factors [12-15]. Reducing the risk from one fac-
tor may decrease the overall risk of SIDS. Placing infants
to sleep on their backs (supine) has substantially reduced
SIDS worldwide, apparently over-riding inherent risk
factors and reducing risk of asphyxia [13,14]. Results
from surveys of Nunavut mothers suggest that only
38-46% of mothers place their infants to sleep on their
backs, compared to 77% for the rest of Canada [16,17].
While it is controversial whether bed-sharing (sharing a
sleep surface with an infant) is a risk factor itself, bed-
sharing is associated with increased risk for SIDS when
combined with other risk factors, including non-supine
sleep position, bed-sharing with a non-caregiver and
bed-sharing with a parent/caregiver who smokes or has
impaired arousal [18,19].
Undiagnosed fatty acid oxidation disorders account
for 3-6% of SIDS and SUDI cases [15,20,21]. The
P479L (c.1436C>T) genetic variant of the hepatic fatty
acid oxidation enzyme, carnitine palmitoyltransferase
1A (CPT1A), has been associated with infant mortality in
Alaska Native and British Columbia coastal First Nations
populations, where the variant is common [22,23]. In
2010, we established that the CPT1A P479L variant is
highly prevalent in Nunavut; more than 70% of infants
born in Kitikmeot and Kivalliq regions of Nunavut were
P479L homozygous (n=290; 2006) [24]. To date, the
P479L variant has only been reported in Indigenous
populations [24,25]. Importantly, the variant has also
been reported to confer positive effects in studies of car-
diovascular lipid profiles and obesity [25,26]. It remains
controversial whether the variant is a risk factor itself for
infant mortality or a marker of other population-based
risk factors more common in high prevalence areas.
Reducing infant mortality is a primary goal of the
2008–2013 Government of Nunavut Public Health Strat-
egy, Developing Healthy Communities [27]. In keepingwith the goal of developing programs to reduce infant
mortality in Nunavut, we report the causes and asso-
ciated risk factors in Nunavut from 1999–2011, using
data from the Nunavut Chief Coroner’s Office, Nunavut
Bureau of Statistics and Statistics Canada [28]. We also
compare Nunavut rates to published national data for




Ethics and regulatory approval was obtained from UBC
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Tunngavik Inc.
Data sources
All infant deaths (live birth with death before 1 year of
age) occurring in Nunavut between July 1, 1999 and
June 30, 2011 and reported to the Nunavut Chief
Coroner’s Office and, subsequently, to the Nunavut
Chief Medical Officer of Health, were reviewed. Infant
deaths recorded by the Nunavut Bureau of Statistics
were also reviewed. This dataset captured all postneona-
tal infant death and a subset of neonatal death. Early
neonatal deaths for those infants born out of territory
where death occurred before registration in Nunavut
were not commonly available. Consequently, ascertain-
ment of perinatal and neonatal deaths was limited for
this review. All prenatally occurring deaths (stillbirths)
were excluded from this review.
Variables collected (when available) were: date of birth,
date of death, cause of death, gender, gestational age at
birth, mother’s place of residence at time of death,
CPT1A P479L genotype, and sleep environment (i.e.
sleep position, sleep surface, loose bedding, bed-sharing).
Sleep environment was obtained from death scene inves-
tigation report. Bed-sharing was defined as those infants
sharing a sleep surface with another person as docu-
mented when the death occurred. Causes of death were as
determined by the Chief Coroner after review of autopsy
reports and death scene investigation. Cases were grouped
into one of four major cause of death categories; SIDS/
SUDI, infection (respiratory, H influenza or other), con-
genital anomaly or other.
Data for live births to mothers residing in Nunavut
for July 1, 1999-June 30, 2011 (n=9215) were obtained
from Statistics Canada [28]. National comparison data
for infant deaths (1998–2007) were obtained from the
Public Health Agency of Canada 2011 Perinatal Health
Indicators for Canada report [29].
When available, CPT1A genotype data for the P479L
variant was collected for unexpected infant death cases
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optimal CPT1A function might influence outcome.
There were 81 unexpected infant death cases during the
review period and CPT1A P479L genotype information
was available for 35 cases. In 2004, the Manitoba New-
born Screening program commenced a pilot CPT1A
P479L newborn screening program for infants born to
Kivalliq region residents [30]. Eighteen of the 35 identi-
fied cases had been previously genotyped during routine
newborn screening as part of that pilot project. The
remaining 17 were genotyped on request of the Chief
Coroner or pathologist performing the autopsy. Our pre-
viously reported data for CPT1A P479L genotypes in
infants born to Nunavut residents in 2006 (n=695) were
used for comparison [24].
Data analysis
Crude mortality rates were calculated per 1,000 live
births by region and for Nunavut [28,31]. Nunavut rates
were compared to Canadian data using odds ratios with
95% confidence intervals (CI). Crude national infant and
postneonatal mortality rates were calculated with avail-
able 1998–2007 data, and crude national cause-specific
mortality rates were calculated with available 2003–2007
data. National rates exclude Ontario [29].
Association (odds ratios with 95% CI) of the P479L vari-
ant with unexpected infant death (SIDS, SUDI and infec-
tion) was analysed by comparing P479L homozygous
cases to the population P479L homozygosity, as estimated
for live born infants undergoing newborn screening in
Nunavut in 2006 [24]. Population data were analysed by
comparing P479L homozygosity between regions usingTable 1 Age and cause specific mortality rates (per 1,000 live
region (n=117; July 1 1999-June 30 2011) and in Canada† (19
Nunavut IMR (95%
Qikiqtani Kivalliq Kit
Live births 4,859 2,817
Mortality Rates
Infant death 10.91 (8.18-14.24) 13.13 (9.26-18.06) 16.89 (
Postneonatal death 8.23 (5.89-11.19) 10.65 (7.20-15.17) 11.70
Cause of Death
SIDS and SUDI 5.76 (3.83-8.32) 5.68 (3.25-9.21) 7.80 (
Infection 2.06 (0.99-3.78) 3.19 (1.46-6.06) 3.25
Respiratory 0.82 (0.22-2.11) 0.71 (0.09-2.56) 1.95
H influenza 0.41 (0.05-1.49) 0.36 (0.01-1.98) 1.30
Other 0.82 (0.22-2.11) 0.00 (0.00-1.31) 0.00
Congenital anomalies 0.41 (0.05-1.49) 0.36 (0.01-1.98) 1.30
* Crude mortality rates for Nunavut were calculated per 1,000 live births.
† Canadian rates (excluding Ontario) of crude infant and postneonatal mortality we
calculated with available 2003–2007 data, as reported by the Public Health Agency
IMR = infant mortality rate. CI = confidence interval.χ2 test with a p<0.05 significance level. Hardy-Weinberg
equilibrium was previously calculated [24].
All statistical analysis was conducted using STATA 11
(StataCorp. 2009. Stata Statistical Software: Release 11.
College Station, TX). Two-tailed p values <0.05 were
considered significant. Due to limited information, risk
associated with sleep practices could not be analysed.
Information on maternal and household characteristics,
including parity, maternal age, maternal education,
household income and food security, were very limited
or not available for this review.Results
There were 117 infant mortality cases documented in
Nunavut between 1999 and 2011. Ninety infant deaths
occurred in Nunavut and were reported to the Chief
Coroner. An additional 27 cases were reported to the
Nunavut Bureau of Statistics, 7 of which occurred in
the territory during the perinatal period (all occurred
on the first day of life); the remaining 20 occurred out
of territory (Edmonton, Winnipeg and Ottawa). Cause
of death was documented for 95 cases.
The leading causes of infant death were SUDI (n=32;
27%), SIDS (n=24; 21%) and infection (n=25; 21%).
Combined, SIDS and SUDI (SIDS/SUDI) comprised
the majority of cases (48%). Cause-specific infant mor-
tality rates for SIDS/SUDI and infections were 6.08
and 2.71/1,000 live births, respectively, and these rates
were significantly increased compared to national rates
(ORs:11.97; 95%CI: 8.9-15.8 and 8.79; 95%CI: 5.6-13.2;







11.06-24.66) 12.70 (10.51-15.20) 5.15 (5.01-5.28) 2.47 (2.04-2.98)
(6.95-18.42) 9.66 (7.76-11.87) 1.39 (1.31-1.46) 6.96 (5.56-8.64)
4.04-13.58) 6.08 (4.59-7.88) 0.51 (0.47-0.55) 11.97 (8.92-15.79)
(1.06-7.57) 2.71 (1.76-4.00) 0.31 (0.28-0.34) 8.79 (5.60-13.21)
(0.40-5.69) 1.63 (0.91-2.68) - -
(0.16-4.69) 0.65 (0.24-1.42) - -
(0.00-2.39) 0.43 (0.12-1.11) - -
(0.16-4.69) 0.54 (0.18-1.27) 1.19 (1.13-1.26) 0.46 (0.15-1.07)
re calculated with available 1998–2007 data and cause-specific mortality were
of Canada in the Perinatal Health Indicators for Canada 2011 report [29].
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region than in the Kivalliq and Qikiqtani regions.
Postneonatal deaths (28–364 days) accounted for 76%
(n=89) of all infant deaths in this review. The crude
postneonatal mortality rate for Nunavut was 9.66/1,000
live births, significantly higher than the national rate of
1.39 (OR=6.96, 95%CI: 5.56-8.64). SIDS/SUDI (n=52,
58%) and infection (n=22, 25%) were the leading causes
of postneonatal death in Nunavut (Figure 1).SIDS and SUDI risk factors
There were 56 SIDS and SUDI cases during the review
period; 86% occurred before 6 months of age. Deaths
were evenly distributed between genders (male=29,
female=27). Gestational age at birth was available for
41 cases, 14 (25%) were born premature (<37 completed
weeks of gestation).
Some information on sleep environment at time of
death was available for 52 of the 56 SIDS/SUDI cases.
Two or more sleep environment risk factors were docu-
mented in 39 cases (70%). Of those cases with documen-
ted sleep position at time of death (n=42), sleep position
was non-supine for 29 (69%). Bed-sharing occurred in
33 of the 47 cases (70%) with that information. Of the
33 cases known to be bed-sharing at time of death,
23 (70%) had two or more additional risk factors present,
including non-supine sleep position, sleeping on a soft
surface (sofa), bed-sharing with a non-caregiver, and/or
smoking or alcohol/illicit drug use by bed-sharer.Death due to infection
Death due to infection was the cause of death for
25 cases. The majority of deaths were due to respiratory
infection (n=15) or Haemophilus influenzae infection
(type a or b; n=6). Two Haemophilus influenzae cases
had a respiratory component. The remaining infectious
causes included herpes simplex virus, granulomatous








Figure 1 Causes of Postneonatal Death in Nunavut (July 1 1999-June
n=1478) [29]. Infection includes deaths due to respiratory or other infectioPrematurity
Gestational age was available for 75 of the total infant
mortality cases, of those, 29 (39%) were born premature
(<37 completed weeks of gestation), representing 25% of
our total review.CPT1A P479L variant and unexpected infant death
CPT1A genotypes were available for 35 of the 81 unex-
pected infant deaths (SIDS/SUDI or infection) during the
review period. Of the 35 cases with genotype, 30 were
P479L homozygous and the remaining 5 were heterozy-
gous. All SIDS/SUDI cases with CPT1A genotype data
(17 P479L homozygous and 5 heterozygous) had other
risk factors for sudden death present, including non-
supine sleep position and/or bed-sharing at time of
death. All infectious death cases were homozygous
(8 respiratory and 5 Haemophilus influenzae).
P479L homozygosity was associated with unexpected
infant death in Nunavut with all regions combined (OR:
3.43, 95%CI: 1.30-11.47; Table 2). Population based P479L
homozygosity was significantly higher in the Kitikmeot
and Kivalliq regions compared to the Qikiqtani region
(χ2=22.86, p<0.0001), suggesting population stratification
in the Qikiqtani region, where the variant is not in
Hardy-Weinberg equilibrium [24].There was no statis-
tical difference in homozygosity between the Kivalliq and
Kitikmeot regions.Discussion
Indigenous populations worldwide experience infant and
postneonatal mortality rates that are substantially higher
than national averages [10,32-34]. This is true in the
Inuit regions of Canada, including the Nunavut territory,
where infant mortality rates are consistently 3 times the
national rate [3,10]. Our review suggests an overall crude
infant mortality rate slightly lower than reported pre-
viously, likely due to under ascertainment of neonatal
deaths. However, postneonatal mortality rates were







30 2011; n=89) and Canada (excludes Ontario; 2003–2007;
ns.
Table 2 Comparison of CPT1A P479L homozygosity in unexpected infant death cases (SIDS, SUDI and infection)





FET pn f (95%CI) n f (95%CI)
NUNAVUT 30 85.7 (69.7-95.2) 442 63.6 (59.9-67.2)* 3.43 (1.30-11.47) 0.006
Qikiqtani 8 88.9 (51.8-99.7) 162 53.6 (47.8-59.4)* 6.91 (0.90- 308.87) 0.044
Kivalliq 16 88.9 (62.5-98.6) 170 70.0 (63.8-75.7) 3.44 (0.77-31.45) 0.108
Kitikmeot 6 75.0 (34.9-96.8) 110 73.3 (65.5-80.2) 1.09 (0.19-11.47) 1.000
Kivalliq & Kitikmeot (combined) 22 84.6 (65.1-95.6) 290 71.2 (66.5-75.7) 2.22 (0.73-9.04) 0.178
* Genotype frequencies deviated from Hardy-Weinberg equilibrium (p<0.05) [24].
f = frequency. CI = confidence interval. FET = fisher’s exact test.
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viously identified as the leading contributors to the
higher rates of postneonatal mortality in indigenous
populations of Western Australia and Alaska [33,34]. In
this review, Nunavut rates of SIDS/SUDI (6.08/1,000)
and infection (2.71/1,000) were significantly higher than
national rates (2003–2007) and consistent with those
previously reported for Inuit-inhabited regions of Canada
(1990–2000) [10]. Additionally, the high rate of SIDS/
SUDI in this review is consistent with or higher than
those reported for indigenous populations in Western
Australia (4.7/1,000; 1998–2001) and Alaska (3.6/1,000;
2000–2003) [33,34].
Sleep environment in SIDS and SUDI cases
We report a SIDS/SUDI rate for Nunavut that is signifi-
cantly higher than the national rate (OR=11.97, 95%CI:
8.92-15.79). Review of sleep environment at time of
death showed 70% of SIDS/SUDI cases had two or more
sleep-related risk factors present. Importantly, non-
supine sleep position was present in 69% of cases with
sleep-position documented, emphasizing the need for
improved safe sleep messaging in Nunavut.
Bed-sharing was also prevalent in SIDS/SUDI cases
(70% of those with bed-sharing information); however,
a majority of cases bed-sharing at time of death had
additional sleep-related risk factors present, including
non-supine sleep position and/or bed-sharing with
non-caregiver(s). This is consistent with the 2006 Abo-
riginal Children’s survey that reports caregivers of Inuit
infants are less likely to place the infant supine for
sleep when bed-sharing [16].
Although our data are limited, our results are consist-
ent with other studies that suggest bed-sharing with add-
itional risk factors present increases risk for SIDS/SUDI
[18,19]. In cultures such as the Inuit culture, where
mothers traditionally and continue to prefer to bed-share
with infants, advising against bed-sharing under all cir-
cumstances may not be easily accepted. Health promo-
tion strategies must consider cultural perspectives and astrong emphasis on risk reduction is crucial [35]. Better
information regarding infant sleep practices in the overall
population and at time of death is needed to assess risk
effectively. In our review, many SIDS/SUDI case reports
did not include full information on sleep environment at
time of death.
Infection
Infection was the second leading cause of infant mortal-
ity during the review period, and had a cause specific
mortality rate of 2.71/1,000 live births. Respiratory infec-
tion comprised the majority of cases. Infants in Nunavut
have the highest reported rate of hospitalisation for lower
respiratory tract infections worldwide, with an average of
306-484/1,000 infants [36,37]. The hospitalization rate
for infants with heart defects is even higher at 800/1,000
infants. Prematurity, tobacco smoke exposure (prenatal
and postnatal), overcrowding and poor ventilation are
all risk factors for respiratory infections and hospital
admissions for Inuit children living in Nunavut [37,38].
Although tobacco smoke exposure data were limited in
this review, environmental tobacco smoke is reported
to be present in ~90% of Nunavut homes, which are
small, overcrowded and have low air change rates [39].
Haemophilus influenzae infection (type a or b) was the
cause of death for 6 cases during the review period. The
International Circumpolar Surveillance system reports
that northern Canada has the highest rate of invasive
Haemophilus influenzae type A in children under the
age of two in the circumpolar region (1999–2006) [40].
From 2009–2010, there were 11 cases under age 2 con-
firmed in Nunavut (G Osborne, personal communication).
Prematurity
Nunavut has an average preterm birth rate of 12%,
which is 1.5 times the Canadian average of 8% [31].
Infants born premature have a 3–6 times higher risk of
mortality than term infants, including higher risks for
deaths due to SIDS and infections [41,42]. Premature
infants comprised at least 25% of the infant mortality
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the early neonatal deaths occurring out of territory were
not available for review. High levels of prenatal exposure
to cigarette smoke increases the risk of premature birth
[41,43]. Although prenatal maternal smoking was not
well documented in the data available for this review, in
other studies 60-80% of Nunavut women self-reported
smoking during pregnancy, almost 5 times the national
average of 13% [43,44]. Mothers who reported smoking
greater than 10 cigarettes per day during pregnancy had
twice the risk of having a premature infant than those
who did not smoke [43].
P479L CPT1A homozygosity in unexpected infant death
cases
CPT1A is an important liver enzyme required to trans-
port long chain fatty acids into the mitochondrion for
use as energy when dietary carbohydrates are unavailable
(i.e. during fasting or prolonged exercise). CPT1A defi-
ciency is a rare autosomal recessive disorder, usually pre-
senting in infancy as non-ketotic hypoglycemia and
metabolic decompensation triggered by fasting, which
can progress to seizures, brain damage, and sudden death
[45]. A small number of Nunavut Inuit infants and chil-
dren, homozygous for the CPT1A P479L variant, have
presented symptomatically with features consistent with
CPT1A deficiency or with sudden unexpected death [30].
In our review, P479L homozygosity was associated
with unexpected infant death (SIDS/SUDI and infection)
in Nunavut as a whole (OR 3.43, 95%CI:1.30-11.47;
p=0.006), which is consistent with results reported for
Alaska Native and British Columbia First Nations popu-
lations [22,23]. However, analysis of the 2006 population
data by region determined that the background preva-
lence of P479L homozygosity was significantly lower in
the Qikiqtani region. Although underpowered, the asso-
ciation of P479L homozygosity with unexpected infant
death was less apparent in the high prevalence regions,
especially in the Kitikmeot region (OR: 1.09, 95% CI:
0.19-11.47), which had the highest rates of postneonatal
mortality, SIDS/SUDI and infant death due to infection.
Although the overall population of Nunavut is small
(~33,000) and the regions often combined, rates of im-
migration and emigration differ between the Nunavut
regions [46]. Population stratification leading to spurious
results is a particular concern in genetic association
studies, especially when geographic sub-sets of small
populations are being evaluated. The significantly lower
P479L homozygosity in the Qikiqtani region may be due
to admixture and/or a higher rate of non-Inuit immigra-
tion from other regions and provinces. Combining all
regions increases the likelihood of a statistically significant
difference if the case population rate is not entirely reflect-
ive of the reference population. Indeed, all postneonataldeaths in our review were born to Inuit mothers, which
may have a higher homozygosity rate than the whole
Qikiqtani region.
At this time we cannot rule out or confirm an asso-
ciated risk with the P479L allele given our small num-
bers. Further study, controlling more precisely for
population stratification is indicated. It remains possible
that the association between the variant and unexpected
infant death represents a complex interaction of the
variant with environmental risk factors including sleep
position, bed-sharing, prenatal and postnatal tobacco
smoke exposure and food security. The ‘triple risk hy-
pothesis’ for SIDS proposes that an external stressor
combines with an underlying vulnerability at a critical
development period to cause a SIDS death [47]. The
P479L variant may represent an underlying vulnerability
(i.e. a predisposition to hypoglycemia) that, when com-
bined with exogenous stressors during a critical develop-
ment period and/or intercurrent illness, may increase
risk for unexpected infant death.
Alternatively, it is possible that the variant when
homozygous serves as a marker of other social, eco-
nomic, cultural or biological factors which increase the
risk for infant mortality. There is suggestion of protect-
ive effect for cardiovascular lipid profiles and obesity in
the Alaska Yupik and Greenland Inuit adults, perhaps in
the context of a traditional diet [25,26]. Given the high
frequency of the variant in Inuit populations pointing to
an historical advantage, the current clinical significance
of the variant remains unclear.Limitations
This was a retrospective case review with incomplete
risk determinant information. Most mortality subgroups
presented in this review were too small for complex stat-
istical analysis. Full ascertainment for CPT1A P479L
genotype, sleep position and bed-sharing was not pos-
sible. Ongoing study is needed to confirm these baseline
results.
Our review was limited to those cases documented in
Nunavut by the Chief Coroner’s Office and the Nunavut
Bureau of Statistics, therefore our dataset under-
represented deaths of cases born out of territory, espe-
cially with death during the first hospitalization (for
example extreme prematurity and severe congenital
anomalies). Therefore it is expected that the neonatal
mortality rate is lower in our study than reported else-
where [3,10].
Information on socioeconomic status (SES), including
maternal education, household income and food secur-
ity, were not available for this review. This may be an
important limitation because of the known association
with low socioeconomic status and infant mortality [48].
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from the recent Inuit Health Survey showing that almost
70% of Nunavut households with preschoolers are either
moderately or severely food insecure, which is more
than 7 times the national average (9%) [49]. On-going
research will address this limitation.Conclusion
Consistent with a previous study of Inuit birth outcomes
in Canada [10], our study suggests a greater proportion
of infants in Nunavut die of SIDS, SUDI or infection
than infants in the rest of Canada. Factors such as sleep
position and bed-sharing may play a role in these deaths.
Although the P479L variant was associated with unex-
pected infant death in Nunavut as a whole, the associ-
ation was less apparent when population stratification
was considered. Population stratification as an under-
lying determinant of this association needs further as-
sessment, as does the association of other potentially
interactive risk factors. Prospective study of the health
outcomes for P479L homozygous infants is planned to
clarify the variant’s role in the health of these individuals,
and the impact, if any, that treatment may have on these
health outcomes.
Improved prenatal and postnatal data collection would
enhance the understanding of the increased rates of in-
fant mortality and inform prevention strategies. Efforts
to improve maternal child health surveillance are now
underway [50]. On-going assessment of the multiple risk
factors involved in infant mortality will inform public
health policy and prevention. Information regarding
sleep position needs to be better communicated in a cul-
turally appropriate manner. Messaging about infant care
and sleep practices should come from within communi-
ties as well as from health care providers.
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